Fecal Occult Testing Market Landscape, Trends And Opportunities Forecast 2021-2027

Precision Business Insights published a research report on “Fecal Occult Testing Market by Product (Immuno-FOB Agglutination Test, Guaiac FOB Stool Test, Immuno-FOB ELISA Test and Lateral Flow Immuno-FOB Test) and End User (Hospitals, Physicians Office Laboratories and Clinical Diagnostic Laboratoroies), By Region (Latin America, North America, Middle East & Africa, Europe, Asia Pacific,) and Geography - Global/Region/Country Forecast to 2027”.

A faecal occult blood test (FOBT) is a non-invasive diagnostic that detects blood in the faeces or stool. It is done utilising cards and flushable reagent pads or tissues to collect samples. These samples are sent to a lab for testing and are used to diagnose disorders that cause bleeding in the digestive tract, such as haemorrhoids, diverticulosis, ulcers, colitis, benign tumours, colon polyps, or cancer. The adoption of Fecal Occult Testing is currently being promoted by an increasing awareness of early screening, since it allows for quick medical decisions, better healthcare, increased quality of life, and a lower mortality rate.

View detailed report description here https://precisionbusinessinsights.com/market-reports/fecal-occult-testing-market/

One of the important reasons driving market expansion is the growing focus on integrated health services for enhanced patient experience and health outcomes, which coincides with a growing preference for point-of-care diagnostics (POCD). Aside from that, the market is being accelerated by the growing elderly population, as the chance of catching diseases grows with age. As a result, multiple FOBT screening programmes for older persons are being implemented by government agencies in various nations. Furthermore, the market is growing due to the rising adoption of minimally invasive (MI) procedures. In addition, immunochemical faecal occult blood tests (iFOBTs or FITs) are gaining popularity due to their ease of use and clinical sensitivity to malignancies and advanced adenomas. The ease with which FOBT devices can be purchased from internet retailers is expected to boost market growth in the future years.

The fecal Occult Testing market can be segmented based on product, end-user, and geography. In terms of product, the fecal occult testing market can be classified into Immuno-FOB agglutination test, guaiac FOB stool test, immuno-FOB ELISA test and lateral flow immuno-FOB test. Based on end-user, the Fecal Occult Testing market can be divided into hospitals, clinical diagnostic laboratories, and physicians' office laboratories.

Due to widespread public awareness and fast rising demand for technologically improved faecal occult blood test kits, North America dominated the global fecal occult testing market. The United States leads the fecal occult testing market in North America, with the highest rate of adoption of point-of-care testing products. The global faecal occult blood test market is dominated by North America, with Europe following closely behind. Increased demand from European countries such as the United Kingdom, Germany, and France for faecal occult blood test kits. The rising prevalence of colon cancer is a primary driver of the fecal occult testing market's expansion.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=46122

Some of the major key players in the fecal occult testing market are Quidel Corporation, EIKEN CHEMICAL CO., LTD, Polymedco CDP, Quest Diagnostics Incorporated, Beckman Coulter, Inc Abbott Laboratories, Randox Biohit Oyj, Laboratories Ltd. and EDP Biotech

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.